GPR34 Receptor Antagonist 2（Cat No.:I035319）is a selective small molecule that inhibits the G protein-coupled receptor 34 (GPR34), a receptor implicated in immune regulation and cancer progression. By blocking GPR34, this compound helps modulate downstream signaling pathways such as PI3K/AKT, potentially reducing inflammatory responses and limiting tumor cell survival or proliferation. It is primarily used in research to explore the therapeutic potential of GPR34 inhibition in inflammatory diseases and cancers like glioblastoma and pancreatic adenocarcinoma. This antagonist serves as a valuable tool in preclinical mechanistic and drug discovery studies.